首页 | 本学科首页   官方微博 | 高级检索  
     

EphA2及其配体EphrinA1在恶性脑胶质瘤中的表达及与血管生成的关系
引用本文:方艳伟,刘力强,邱文娜,瓮杰慧,耿少梅,焦保华. EphA2及其配体EphrinA1在恶性脑胶质瘤中的表达及与血管生成的关系[J]. 中国肿瘤临床, 2013, 40(18): 1111-1115. DOI: 10.3969/j.issn.1000-8179.20130697
作者姓名:方艳伟  刘力强  邱文娜  瓮杰慧  耿少梅  焦保华
作者单位:河北医科大学第二医院神经外科(石家庄市050000)
摘    要:  目的  检测酪氨酸激酶受体EphA2及其配体EphrinA1在恶性脑胶质瘤中的表达,并探讨其与胶质瘤血管生成的关系。  方法  采用免疫组织化学S-P法检测62例胶质瘤组织及8例正常脑组织中EphA2、EphrinA1的表达情况,并采用CD105抗体标记微血管内皮细胞,计算微血管密度(microvesseldensity,MVD)。探讨EphA2、EphrinA1的表达水平与胶质瘤的微血管生成之间可能存在的关系。  结果  EphA2、MVD在胶质瘤中阳性表达明显高于正常脑组织,二者差异显著(P<0.01)。而且随着肿瘤恶性程度增加,EphA2及MVD蛋白染色强度和阳性细胞数均明显升高,高级别脑胶质瘤(Ⅲ~Ⅳ)中EphA2及MVD强阳性表达明显高于低级别胶质瘤组,差异有显著统计学意义(P<0.01)。EphrinA1则具有相反的趋势,在大多数恶性脑胶质瘤中呈低水平表达,在低级别胶质瘤和正常组织中呈较高水平表达,且胶质瘤级别越低EphrinA1表达越高。EphA2表达与MVD呈显著正相关(r=0.713,P<0.01),EphrinA1表达与MVD呈显著负相关(r=-0.772,P<0.01),EphA2的表达与EphrinA1呈显著负相关(r=-0.912,P<0.01)。  结论  EphA2在恶性脑胶质瘤中特异性高表达、EphrinA1特异性低表达与胶质瘤的侵袭性和恶性程度密切相关,且EphA2过表达和EphrinA1的缺陷表达可能协同促进胶质瘤组织新生血管的生成,在胶质瘤的发病及恶性进展中发挥重要作用。 

关 键 词:脑胶质瘤   EphA2   EphrinA1   CD105微血管密度   血管生成
收稿时间:2013-05-05

EphA2/ephrinA1 expression in human malignant gliomas and its relationship with angiogenesis
Yanwei FANG , Liqiang LIU , Wenna QIU , Jiehui WENG , Shaomei GENG , Baohua JIAO. EphA2/ephrinA1 expression in human malignant gliomas and its relationship with angiogenesis[J]. Chinese Journal of Clinical Oncology, 2013, 40(18): 1111-1115. DOI: 10.3969/j.issn.1000-8179.20130697
Authors:Yanwei FANG    Liqiang LIU    Wenna QIU    Jiehui WENG    Shaomei GENG    Baohua JIAO
Affiliation:Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
Abstract:  Objective  To investigate the expressions and significance of tyrosine kinase receptor EphA2 and its ligand ephrinA1 in human malignant gliomas and their correlation with tumor angiogenesis.  Methods  The expressions of EphA2, ephrinA1, and CD105-stained microvessel density (MVD) were detected via immunohistochemical assay in 62 glioma tissues and 8 normal brain tissues. The correlation between EphA2 and ephrinA1 expression and microvessel counts in the glioma tissues were assessed.  Results  Immunohistochemical staining results revealed that variable levels of EphA2 and MVD expression were significantly higher than that of the normal brain samples. Statistical difference was observed in EphA2 and MVD expressions between human gliomas and normal brain samples (P<0.01). The positive rate of EphA2 and MVD expressions was significantly higher in high-grade gliomas (WHO Ⅲ-Ⅳ) than that in low-grade gliomas (WHO Ⅰ-Ⅱ)(P<0.01). EphrinA1 was expressed at low levels in most malignant gliomas, and the increased ephrinA1 expression was associated with lower-grade histology. MVD was significantly positively correlated with EphA2 expression (r=0.713, P<0.01) and significantly negatively correlated with ephrinA1 expression (r=-0. 772, P<0.01). EphA2 was significantly negatively correlated with ephrinA1 expression (r=-0.912, P<0.01).  Conclusion  Specifically over-expressed EphA2 and its low-expressed ligand ephrinA1 in malignant gliomas may be closely correlated with the invasion and malignant degree of gliomas. Cooperation is involved in the angiogenesis and has an important function in the initiation and progression of gliomas. 
Keywords:gliomas  EphA2  EphrinA1  CD105-MVD  angiogenesis
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号